Description: PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its pipeline products include Cannabinoid Sol-Gel Delivery, a cannabinoid-based nose-to-brain delivery system that provides relief from various indications, including pain, inflammation, seizures, and neurological disorders; Non-Addictive Analgesic for pain management; BSV Peptide Program that targets cancer progression; and Dual Gene Therapy for type 2 diabetes and obesity. PreveCeutical Medical Inc. is headquartered in West Vancouver, Canada.
Home Page: www.preveceutical.com
5428 Marine Drive
West Vancouver,
BC
V7W 2R2
Canada
Phone:
604 416 7777
Officers
| Name | Title |
|---|---|
| Mr. Stephen Van Deventer | Chairman, CEO & CFO |
| Dr. Makarand Jawadekar Ph.D. | Chief Science Officer, President & Director |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 1973.4153 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |